Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IMRA

IMARA (IMRA) Stock Price, News & Analysis

IMARA logo

About IMARA Stock (NASDAQ:IMRA)

Advanced Chart

Key Stats

Today's Range
$49.84
$50.45
50-Day Range
$6.32
$25.28
52-Week Range
$0.97
$6.32
Volume
10,028 shs
Average Volume
138,364 shs
Market Capitalization
$1.32 billion
P/E Ratio
1,008.99
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IMRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMARA and its competitors with MarketBeat's FREE daily newsletter.

IMRA Stock News Headlines

Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late.
Imara Blume
Imara Announces Stockholder Approval of Merger With Enliven
Imara 10% Owner Trades $336K In Company Stock
See More Headlines

IMRA Stock Analysis - Frequently Asked Questions

IMARA Inc. (NASDAQ:IMRA) issued its earnings results on Tuesday, November, 9th. The company reported ($2.20) EPS for the quarter, topping the consensus estimate of ($3.64) by $1.44.

IMARA's stock reverse split on the morning of Friday, February 24th 2023.The 1-4 reverse split was announced on Friday, February 24th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

IMARA (IMRA) raised $76 million in an initial public offering on Thursday, March 12th 2020. The company issued 4,500,000 shares at $16.00-$18.00 per share. Morgan Stanley, Citigroup and SVB Leerink acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that IMARA investors own include NIO (NIO), Novavax (NVAX), NVIDIA (NVDA), Axsome Therapeutics (AXSM), Alibaba Group (BABA), AMC Entertainment (AMC) and BioXcel Therapeutics (BTAI).

Company Calendar

Last Earnings
11/09/2021
Today
7/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:IMRA
Phone
N/A
Fax
N/A
Employees
41
Year Founded
N/A

Profitability

Trailing P/E Ratio
1,008.99
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$1.49 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.67 per share
Price / Cash Flow
75.24
Book Value
$3.44 per share
Price / Book
14.66

Miscellaneous

Free Float
16,449,000
Market Cap
$1.32 billion
Optionable
Not Optionable
Beta
1.09
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:IMRA) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners